Investors & Media International Stem Cell Corporation Formalizes Stem Cell-Based Eye Care Programs into Cytovis™ International Stem Cell Corporation and Sristi Biosciences Enter into Distribution Agreement for Lifeline Cell Technology's Brand of Human Cell Culture Products in India International Stem Cell Plans $10 Million Financing Through European Subsidiary International Stem Cell Corporation and Insight Bioventures Seek to Establish Indian Operations International Stem Cell Corporation (ISCO.OB) and Sankara Nethralaya Launch Collaboration to Develop Stem Cell-Based Treatment for Corneal Vision Impairment International Stem Cell Corporation (ISCO.OB) Announces New Patent Issuance Under License Agreement International Stem Cell Corporation Names Charles J. Casamento to Board of Directors International Stem Cell Corporation Announces Company Update Conference Call International Stem Cell Corporation's Parthenogenetic Stem Cell Patent is Approved by the United States Patent and Trademark Office International Stem Cell Corporation Moves International Cornea Development Program Forward 21 22 23 24 25 26 27 28 29 30 31 << < > >>
